Health Catalyst Announces Board and Executive Changes
Ticker: HCAT · Form: 8-K · Filed: Sep 10, 2025 · CIK: 1636422
| Field | Detail |
|---|---|
| Company | Health Catalyst, Inc. (HCAT) |
| Form Type | 8-K |
| Filed Date | Sep 10, 2025 |
| Risk Level | medium |
| Pages | 5 |
| Reading Time | 6 min |
| Key Dollar Amounts | $0.001, $475,000, $41.5 million, $12.5 million, $1,209,872 |
| Sentiment | neutral |
Sentiment: neutral
Topics: management-change, filing
Related Tickers: HCAT
TL;DR
Health Catalyst (HCAT) filed an 8-K on 9/10/25 detailing board and exec comp changes.
AI Summary
On September 10, 2025, Health Catalyst, Inc. filed an 8-K report detailing changes in its board of directors and executive compensation arrangements. The filing also includes information on Regulation FD disclosures and financial statements/exhibits. Specific details regarding the departures, elections, appointments, and compensatory arrangements are provided within the document.
Why It Matters
Changes in a company's board of directors and executive compensation can signal shifts in strategic direction or governance, potentially impacting investor confidence and future performance.
Risk Assessment
Risk Level: medium — Changes in executive leadership and compensation can sometimes precede or accompany significant strategic shifts or financial performance changes, warranting closer investor scrutiny.
Key Players & Entities
- Health Catalyst, Inc. (company) — Registrant
- 001-38993 (company) — Commission File Number
- 45-3337483 (company) — EIN
- September 10, 2025 (date) — Date of earliest event reported
FAQ
What specific items are covered in the 8-K filing by Health Catalyst, Inc. on September 10, 2025?
The 8-K filing covers the departure of directors or certain officers, election of directors, appointment of certain officers, compensatory arrangements of certain officers, Regulation FD disclosures, and financial statements and exhibits.
What is the exact name of the registrant as specified in its charter?
The exact name of the registrant is Health Catalyst, Inc.
In which state was Health Catalyst, Inc. incorporated?
Health Catalyst, Inc. was incorporated in Delaware.
What is the Commission File Number for Health Catalyst, Inc.?
The Commission File Number for Health Catalyst, Inc. is 001-38993.
What is the business address of Health Catalyst, Inc.?
The business address of Health Catalyst, Inc. is 10897 SOUTH RIVER FRONT PARKWAY, #300, SOUTH JORDAN, UT 84095.
Filing Stats: 1,606 words · 6 min read · ~5 pages · Grade level 11.4 · Accepted 2025-09-10 17:20:07
Key Financial Figures
- $0.001 — ich registered Common Stock, par value $0.001 per share HCAT The Nasdaq Global Select
- $475,000 — fer Letter, Mr. Albert's salary will be $475,000 and he will be eligible for an annual b
- $41.5 million — eive (i) consideration of approximately $41.5 million of cash (the Closing Cash Consideration
- $12.5 million — te consideration of up to approximately $12.5 million in cash (the Earn-Out Cash Consideratio
- $1,209,872 — as a result, received (i) approximately $1,209,872 in cash comprising Closing Cash Conside
Filing Documents
- hcat-20250910.htm (8-K) — 39KB
- exhibit101offerletterbenja.htm (EX-10.1) — 20KB
- exhibit991-pressreleasefor.htm (EX-99.1) — 14KB
- healthcatalystlogo1a.jpg (GRAPHIC) — 10KB
- 0001636422-25-000133.txt ( ) — 218KB
- hcat-20250910.xsd (EX-101.SCH) — 2KB
- hcat-20250910_lab.xml (EX-101.LAB) — 22KB
- hcat-20250910_pre.xml (EX-101.PRE) — 13KB
- hcat-20250910_htm.xml (XML) — 3KB
Forward-Looking Statements
Forward-Looking Statements This Current Report on Form 8-K contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding the commencement of Mr. Albert's role as President and Chief Operating Officer. Any forward-looking statements contained in this Current Report on Form 8-K are based upon the Company's historical performance and its current plans, estimates, and expectations, and are not a representation that such plans, estimates, or expectations will be achieved. These forward-looking statements represent the Company's expectations as of the date of this Current Report on Form 8-K, and involve risks, uncertainties, and assumptions. The actual results may differ materially from those anticipated in the forward-looking statements as a result of numerous factors, many of which are beyond the control of the Company, including the risks and uncertainties disclosed in the Company's reports filed from time to time with the Securities and Exchange Commission, including its most recent Form 10K and any subsequent filings on Forms 10-Q or 8-K, available at www.sec.gov. Except as required by law, the Company does not intend to update any forward-looking statement contained in this Current Report on Form 8-K to reflect events or circumstances arising after the date hereof.
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 10.1#* Offer Letter, dated September 5, 2025, between Health Catalyst, Inc. and Benjamin Albert 10. 2 #** Form of Indemnification Agreement, between Health Catalyst, Inc. and each of its executive officers 10.3#*** Executive Severance Plan 99.1**** Press Release issued by Health Catalyst, Inc. on September 10, 2025 104 Cover page Interactive Data File (embedded within the Inline XBRL document) * Filed herewith. ** Incorporated by reference to Exhibit 10.18 to the Form S-1 filed June 27, 2019. *** Incorporated by reference to Exhibit 10.16 to the Form S-1/A filed July 12, 2019. **** Furnished herewith. # Indicates management contract or compensatory plan. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. HEALTH CATALYST, INC. Date: September 10, 2025 By: /s/ Jason Alger Jason Alger Chief Financial Officer